Trial Profile

Effect of Fenofibrate and Ezetimibe Combination Treatment on Lipid.

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 13 May 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Ezetimibe (Primary) ; Fenofibrate (Primary)
Indications Hyperlipoproteinaemia type IIb
Focus Therapeutic Use
Acronyms EFECTL

Most Recent Events

23 Jan 2019 Status changed from recruiting to completed.
05 Jan 2012 Planned end date changed from 1 Aug 2010 to 1 Dec 2014 as reported by University Hospital Medical Information Network - Japan.
21 Dec 2010 Actual initiation date changed from 2 Jun 2008 to Jul 2008 as reported by University Hospital Medical Information Network - Japan.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com